121 related articles for article (PubMed ID: 19023367)
1. [Choice of PT-INR instruments in primary health care].
Stavelin A; Omenås B; Bolann B; Christensen NG; Sandberg S
Tidsskr Nor Laegeforen; 2008 Nov; 128(22):2620. PubMed ID: 19023367
[No Abstract] [Full Text] [Related]
2. External quality assessment for prothrombin time/international normalised ratio using point-of-care devices: split-sample or conventional external quality assessment using control samples?
Kitchen D; Murray E; Kitchen S; Jennings I; Fitzmaurice D; Woods T; Walker I
Scand J Clin Lab Invest; 2007; 67(7):673-5; author reply 676-7. PubMed ID: 17963156
[No Abstract] [Full Text] [Related]
3. External quality assessment of CoaguChek point-of-care testing prothrombin time/international ratio monitors.
Kitchen S; Kitchen D; Jennings I; Woods T; Walker I
Am J Clin Pathol; 2008 May; 129(5):825-6. PubMed ID: 18481407
[No Abstract] [Full Text] [Related]
4. External quality assessment of prothrombin time: the split-sample model compared with external quality assessment with commercial control material.
Sølvik UØ; Stavelin A; Christensen NG; Sandberg S
Scand J Clin Lab Invest; 2006; 66(4):337-49. PubMed ID: 16777762
[TBL] [Abstract][Full Text] [Related]
5. Comparability of the results of PT-INR with local MNPT and APTTR with MNAPTT on different coagulation analyzers in China.
Peng L; Yan C; Wu X; Nie L
Int J Lab Hematol; 2009 Jun; 31(3):352-8. PubMed ID: 18510575
[TBL] [Abstract][Full Text] [Related]
6. Sample carryover in PT-INR determination is it an issue in Oral Anticoagulant Therapy control?
Corno AR; Redaelli R; Caimi TM; Mostarda G; Caruso R; Morra E
Thromb Res; 2011 Mar; 127(3):279-81. PubMed ID: 21129767
[No Abstract] [Full Text] [Related]
7. Local INR calibration of the Owren type prothrombin assay greatly improves the intra- and interlaboratory variation. A three-year follow-up from the Swedish national external quality assessment scheme.
Hillarp A; Egberg N; Nordin G; Stigendal L; Fagerberg I; Lindahl TL
Thromb Haemost; 2004 Feb; 91(2):300-7. PubMed ID: 14961158
[TBL] [Abstract][Full Text] [Related]
8. A national field study of quality assessment of CoaguChek point-of-care testing prothrombin time monitors.
Meijer P; Kluft C; Poller L; van der Meer FJ; Keown M; Ibrahim S; van den Besselaar AM; Tripodi A; Jespersen J
Am J Clin Pathol; 2006 Nov; 126(5):756-61. PubMed ID: 17050073
[TBL] [Abstract][Full Text] [Related]
9. [Analysis of prothrombin time in primary health care].
Trydal T; Bolann B; Brosstad F; Sandberg S; Sandset PM; Stavelin A; Steensland H; Thue G; Ødegaard OR
Tidsskr Nor Laegeforen; 2005 Aug; 125(15):2048-9. PubMed ID: 16100552
[No Abstract] [Full Text] [Related]
10. False incoagulable PT-INR results in oral anticoagulant therapy.
Redaelli R; Corno AR; Somaini MG; Gechtman C; Caimi TM; Baudo F; Morra E
Thromb Res; 2008; 122(1):137-9. PubMed ID: 17996923
[No Abstract] [Full Text] [Related]
11. A global quality control system to check PT-INR portable monitor for Antivitamin K antagonists.
Testa S; Paoletti O; Bassi L; Dellanoce C; Morandini R; Lippi G
Int J Lab Hematol; 2015 Feb; 37(1):71-8. PubMed ID: 24731219
[TBL] [Abstract][Full Text] [Related]
12. [Less variation in laboratory results after the introduction of INR. Differences between hospital laboratories and laboratories within primary health care are levelled out].
Hillarp A; Egberg N; Fagerberg I; Lindahl TL; Nordin G; Stigendal L
Lakartidningen; 2002 Dec; 99(50):5068-70, 5073-4. PubMed ID: 12572298
[TBL] [Abstract][Full Text] [Related]
13. Review article: the prothrombin time test as a measure of bleeding risk and prognosis in liver disease.
Tripodi A; Caldwell SH; Hoffman M; Trotter JF; Sanyal AJ
Aliment Pharmacol Ther; 2007 Jul; 26(2):141-8. PubMed ID: 17593061
[TBL] [Abstract][Full Text] [Related]
14. Local international normalised ratio (INR) derivation simplified using the European concerted action on anticoagulation (ECAA) prothrombin time/INR line.
Poller L; Jespersen J
Thromb Res; 2011 Aug; 128(2):101-2. PubMed ID: 21658749
[No Abstract] [Full Text] [Related]
15. Comparison and evaluation of a Point-of-care device (CoaguChek XS) to Owren-type prothrombin time assay for monitoring of oral anticoagulant therapy with warfarin.
Wieloch M; Hillarp A; Strandberg K; Nilsson C; Svensson PJ
Thromb Res; 2009 Jul; 124(3):344-8. PubMed ID: 19423152
[TBL] [Abstract][Full Text] [Related]
16. Preparation of control blood for external quality assessment of point-of-care international normalized ratio testing in the Netherlands.
van den Besselaar AM; Abdoel CF; Ardanary D; van de Kamp G; Versluijs FA
Am J Clin Pathol; 2014 Jun; 141(6):878-83. PubMed ID: 24838333
[TBL] [Abstract][Full Text] [Related]
17. Point-of-care (POCT) prothrombin time monitors: is a periodical control of their performance useful?
Barcellona D; Fenu L; Cornacchini S; Marongiu F
Thromb Res; 2009 Mar; 123(5):775-9. PubMed ID: 18814903
[TBL] [Abstract][Full Text] [Related]
18. Internal quality control of prothrombin time in primary care: comparing the use of patient split samples with lyophilised control materials.
Stavelin A; Petersen PH; Sølvik U; Sandberg S
Thromb Haemost; 2009 Sep; 102(3):593-600. PubMed ID: 19718482
[TBL] [Abstract][Full Text] [Related]
19. Prothrombin time international normalized ratio monitoring by self-testing.
Tripodi A
Curr Opin Hematol; 2004 May; 11(3):141-5. PubMed ID: 15257011
[TBL] [Abstract][Full Text] [Related]
20. CoaguChek point-of-care testing prothrombin time monitors.
Braun SL
Am J Clin Pathol; 2007 Oct; 128(4):671-2; author reply 672. PubMed ID: 17924500
[No Abstract] [Full Text] [Related]
[Next] [New Search]
